The use of LMWH in pregnancies at risk: new evidence or perception?

Authors


S. Middeldorp, Department of Vascular Medicine, Academic Medical Center, F4-277, and Dutch Cochrane Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Tel.: +31 20 5665976; fax: +31 20 6968833; e-mail: s.middeldorp@amc.uva.nl

No abstract is available for this article.

Ancillary